Si-Yu Zeng

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsMedical virologyCardiology (incl. cardiovascular diseases)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 25, 2020
Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2.

Si-Yu Zeng, Qiu-Jiang Yan, Li Yang

|Apr 07, 2019
Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.

Si-Yu Zeng, Li Yang, Hui-Qin Lu

|Sep 07, 2018
Protein Arginine Methyltransferase 2 Inhibits Angiotensin II-Induced Proliferation and Inflammation in Vascular Smooth Muscle Cells.

Si-Yu Zeng, Jing-Fei Luo, Hai-Yan Quan

|Aug 15, 2018
A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy.

Si-Yu Zeng, Hui-Qin Lu, Qiu-Jiang Yan

|Jul 27, 2018
Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells.

Si-Yu Zeng, Li Yang, Chen-Liang Hong

Pageof 1

Frequent Collaborators

3 joint publications

Hui-Qin Lu

2 joint publications

Xu-Ping Qin

2 joint publications

Qiu-Jiang Yan

1 joint publications

Jian Zou